(FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | (Q1)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 8.80%116.44B | 14.18%31.27B | -7.09%27.45B | 12.63%29.73B | 18.14%27.99B | 43.68%107.02B | 33.53%27.39B | 53.96%29.54B | 41.85%26.4B | 46.46%23.69B |
Cost of revenue | 6.08%64.83B | 7.54%17.4B | -15.16%14.82B | 15.26%16.88B | 22.72%15.74B | 48.73%61.11B | 43.03%16.18B | 61.66%17.47B | 47.64%14.64B | 41.62%12.82B |
Gross profit | 12.43%51.61B | 23.77%13.87B | 4.61%12.63B | 9.37%12.86B | 12.74%12.26B | 37.46%45.91B | 21.85%11.21B | 44.04%12.07B | 35.21%11.75B | 52.63%10.87B |
Operating expense | 11.60%39.99B | 0.03%10.46B | 1.67%10.04B | 24.28%10.02B | 27.30%9.48B | 34.46%35.84B | 23.99%10.46B | 49.70%9.87B | 38.58%8.06B | 28.22%7.45B |
Staff costs | 14.39%7.64B | ---- | ---- | ---- | ---- | 17.60%6.68B | ---- | ---- | ---- | ---- |
Selling and administrative expenses | 5.90%17.48B | ---- | ---- | ---- | ---- | 42.02%16.51B | ---- | ---- | ---- | ---- |
-Selling and marketing expense | 5.90%17.48B | ---- | ---- | ---- | ---- | 42.02%16.51B | ---- | ---- | ---- | ---- |
Research and development costs | 7.97%1.72B | ---- | ---- | ---- | ---- | 20.32%1.59B | ---- | ---- | ---- | ---- |
Depreciation and amortization | 59.82%1.45B | ---- | ---- | ---- | ---- | 6.59%906M | ---- | ---- | ---- | ---- |
-Depreciation | 65.68%1.41B | ---- | ---- | ---- | ---- | 7.07%848M | ---- | ---- | ---- | ---- |
-Amortization | -25.86%43M | ---- | ---- | ---- | ---- | 0.00%58M | ---- | ---- | ---- | ---- |
Other operating expenses | 15.31%11.71B | ---- | ---- | ---- | ---- | 41.45%10.15B | ---- | ---- | ---- | ---- |
Operating profit | 15.37%11.62B | 353.86%3.41B | 17.76%2.59B | -23.18%2.84B | -18.93%2.78B | 49.34%10.07B | -1.70%752M | 23.15%2.2B | 28.41%3.69B | 160.50%3.42B |
Net non-operating interest income (expenses) | -88.89%5M | -18.18%9M | -140.00%-4M | -94.74%1M | -120.00%-1M | 95.65%45M | 57.14%11M | 42.86%10M | 137.50%19M | 400.00%5M |
Non-operating interest income | -3.96%97M | 24.14%36M | -14.81%23M | -32.26%21M | 21.43%17M | 102.00%101M | 93.33%29M | 92.86%27M | 121.43%31M | 100.00%14M |
Non-operating interest expense | 64.29%92M | 50.00%27M | 58.82%27M | 66.67%20M | 100.00%18M | 107.41%56M | 125.00%18M | 142.86%17M | 100.00%12M | 50.00%9M |
Net investment income | 239.05%438M | 574.07%128M | 70.51%-261M | -36.07%117M | 9.66%454M | -192.38%-315M | -112.68%-27M | -1,329.17%-885M | 438.24%183M | 1,781.82%414M |
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
Income from associates and other participating interests | ||||||||||
Special income (charges) | 37.09%547M | -45.71%38M | 7,171.43%509M | 0 | 0 | -30.61%399M | 12.90%70M | -97.97%7M | 11M | 311M |
Less:Other special charges | -37.09%-547M | 45.71%-38M | ---- | ---- | ---- | -128.00%-399M | -1,300.00%-70M | -250.00%-7M | ---11M | ---311M |
Other non-operating income (expenses) | -17.56%108M | -9.76%37M | 3.13%33M | -46.34%22M | -5.88%16M | -5.76%131M | 7.89%41M | -38.46%32M | 32.26%41M | -5.56%17M |
Income before tax | 23.12%12.71B | 330.20%3.62B | 110.56%2.87B | -24.63%2.98B | -22.20%3.25B | 31.99%10.32B | -22.27%841M | -39.75%1.36B | 26.63%3.95B | 207.14%4.17B |
Income tax | 29.36%3.82B | 405.85%1.04B | 311.76%980M | -27.50%994M | -28.97%809M | 44.68%2.95B | -46.61%205M | -54.75%238M | 90.42%1.37B | 177.13%1.14B |
Net income | 20.62%8.89B | 305.82%2.58B | 68.03%1.89B | -23.09%1.98B | -19.66%2.44B | 27.51%7.37B | -9.01%636M | -35.18%1.13B | 7.51%2.58B | 220.06%3.03B |
Net income continuous operations | 20.62%8.89B | 305.82%2.58B | 68.03%1.89B | -23.10%1.98B | -19.66%2.44B | 27.51%7.37B | -8.88%636M | -35.21%1.13B | 7.47%2.58B | 220.17%3.03B |
Noncontrolling interests | -18.42%31M | -75.00%2M | -50.00%9M | 50.00%9M | 83.33%11M | 38M | 8M | 18M | 6M | 6M |
Net income attributable to the company | 20.84%8.86B | 310.83%2.58B | 69.95%1.88B | -23.27%1.97B | -19.87%2.42B | 26.83%7.33B | -10.16%628M | -36.21%1.11B | 7.22%2.57B | 219.43%3.03B |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | 20.84%8.86B | 310.83%2.58B | 69.95%1.88B | -23.27%1.97B | -19.87%2.42B | 26.83%7.33B | -10.16%628M | -36.21%1.11B | 7.22%2.57B | 219.43%3.03B |
Gross dividend payment | ||||||||||
Basic earnings per share | 21.89%102.45 | 313.02%29.82 | 74.53%22.2 | -23.17%22.61 | -19.78%27.82 | 27.14%84.05 | -10.09%7.22 | -36.05%12.72 | 7.53%29.43 | 220.52%34.68 |
Diluted earnings per share | 21.89%102.45 | 313.82%29.819 | 71.18%21.7634 | -23.22%22.5969 | -19.78%27.82 | 27.14%84.05 | -10.06%7.2058 | -36.08%12.7139 | 7.53%29.43 | 220.52%34.68 |
Dividend per share | 40.00%14 | 40.00%7 | 0 | 40.00%7 | 0 | 66.67%10 | 66.67%5 | 0 | 66.67%5 | 0 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
No Data